ARK Oxcarbazepine Metabolite Assay, ARK Oxcarbazepine Metabolite Calibrator, ARK Oxcarbazepine Metabolite Control

FDA 510(k) K153596 · Ark Diagnostics, Inc.

Substantially Equivalent

510(k) numberK153596

Submission

Device name
ARK Oxcarbazepine Metabolite Assay, ARK Oxcarbazepine Metabolite Calibrator, ARK Oxcarbazepine Metabolite Control
Applicant
Ark Diagnostics, Inc.
Fremont, CA, US
Received
December 16, 2015
Decision date
August 9, 2016
Decision
Substantially Equivalent (SESE)
Type
Traditional 510(k)
Summary
510(k) summary available from FDA

Official FDA 510(k) record

Device classification

Product code
POX – Enzyme Immunoassay, Oxcarbazepine Metabolite
Device class
Class II (moderate risk)
Regulation
21 CFR 862.3645
Specialty
Clinical Toxicology

An Oxcarbazepine Metabolite Assay is an enzyme immunoassay intended for the quantitative determination of Oxcarbazepine Metabolite in human serum. The measurements obtained are used in monitoring levels of Oxcarbazepine Metabolite to help ensure appropriate therapy.

More from Ark Diagnostics, Inc.

510(k)DeviceDecision
K232522ARK Levetiracetam II AssayORI · Traditional 02/27/2024SE
K232017ARK Methotrexate II AssayLAO · Traditional 12/20/2023SE
K231752ARK Hydrocodone AssayDJG · Traditional 11/09/2023SE
K201089ARK Lacosamide AssayNWM · Traditional 08/05/2021SE
K200197ARK Fentanyl II AssayDJG · Traditional 02/26/2020SE
K182280ARK Tramadol AssayDJG · Traditional 12/10/2018SE
K182779ARK EDDP AssayDJR · Traditional 11/21/2018SE
K180427ARK Fentanyl AssayDJG · Traditional 06/06/2018SE
K163359ARK Methotrexate AssayLAO · Special 08/18/2017SE
K111904Ark Methotrexate Assay, Ark Methotrexate Calibrator, Ark Methotrexate Control, Ark…LAO · Traditional 10/18/2011SE

Questions and answers

When was ARK Oxcarbazepine Metabolite Assay, ARK Oxcarbazepine Metabolite Calibrator, ARK Oxcarbazepine Metabolite Control cleared by the FDA?

ARK Oxcarbazepine Metabolite Assay, ARK Oxcarbazepine Metabolite Calibrator, ARK Oxcarbazepine Metabolite Control (K153596) received a 510(k) decision of Substantially Equivalent on August 9, 2016, 237 days after the submission was received.

What is the product code of K153596?

The FDA product code is POX – Enzyme Immunoassay, Oxcarbazepine Metabolite, a Class II (moderate risk) device regulated under 21 CFR 862.3645.